As part of Bina’s ABC meetings, we hosted Dr. Eyal Ben Ami, Associate - Science Lead at M Ventures, the corporate venture capital arm of Merck.
M Ventures invests in early-stage biotech and health-tech companies, sitting right at the intersection of cutting-edge science and global industry.
Eyal took us on a journey from the lab bench to the investor’s chair - from academic research in neuroimmunology, through roles in drug development companies and biotech startups, to his current position as an investor in a corporate VC fund.
